Notice of Additional Information for Funding Opportunity RFA-RM-22-020, NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
Notice Number:
NOT-RM-22-017

Key Dates

Release Date:

June 16, 2022

Related Announcements

RFA-RM-22-020 - NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)

Issued by

Office of Strategic Coordination (Common Fund)

Purpose

The purpose of this Notice is to inform potential applicants of the website address for the optional tool to help prescreen draft Specific Aims and Research Strategy components and provide general feedback regarding responsiveness to the anonymization instructions in the FOA.

Section IV. Application and Submission Information

PHS 398 Research Plan

Currently Reads:

To help prospective applicants identify potential non-responsive text, an optional online tool will be made available. The link to the tool will be provided on the Transformative Research Award website: https://commonfund.nih.gov/TRA. Given the complexity of language and context, the tool does not provide a definitive determination on responsiveness. The applicant bears the sole responsibility to determine the text to include in the application. All applications will be checked for responsiveness by NIH after submission and will be administratively withdrawn if found to be non-responsive.

Revised to read:

To help prospective applicants identify potential non-responsive text in the Specific Aims and Research Strategy components, an optional online tool (TRAAC – TRA Anonymization Check) is available. The link to the tool is https://drm.csr.nih.gov/traac/home. The tool will scan submitted text and provide general feedback about responsiveness. Given the complexity of language and context, the tool does not provide a definitive determination. Further disclaimers are noted on the TRAAC website. The applicant bears the sole responsibility to determine the text to include in the application. All applications will be checked for responsiveness by NIH after submission. Any application found to be non-responsive will be administratively withdrawn.

Inquiries

Please direct all inquiries to:

Ravi Basavappa, Ph.D.
Office of the Director (OD)
Telephone: 301-435-7204
Email: [email protected]